Women in the ATTAIN-1 study lost up to 30.4 pounds (14.4%) over 72 weeks
This concern remains largely theoretical for sermorelin given its physiological rather than supraphysiological effects, but those with history of cancer should consult healthcare providers
Weight Loss Clinic in Winter Garden Medi-Weightloss Winter Garden In-person providers FSA & HSA eligible Doctor recommended Quick Links How to get started Book your appointment or first visit Schedule online or call the clinic directly to get started
We dont take shortcuts, and we dont hide behind vague COAs from inconsistent international labs or slick marketing
Patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use GLP-1 receptor agonists due to thyroid C-cell tumor risk observed in animal studies
Patients who discontinued GLP-1s had more weight gain, complications during pregnancy In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders during pregnancy, and experienced preterm delivery more so than people who had never taken GLP-1 drugs
